Protective effect of rat aldo-keto reductase (AKR1C15) on endothelial cell damage elicited by 4-hydroxy-2-nonenal

Chemico-Biological Interactions

Volumn 191, Issue 1-3, 2011, Pages 364-370

  Matsunaga, Toshiyuki ^a   Shinoda, Yuhki ^a   Inoue, Yukari ^a   Endo, Satoshi ^a   El Kabbani, Ossama ^b   Hara, Akira ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b MONASH UNIVERSITY   (Australia)

Author keywords

4 Hydroxy 2 nonenal; AKR1C15; Aldo keto reductase superfamily; Apoptosis; Endothelial cells; Oxidative stress

Indexed keywords

4 HYDROXYNONENAL; ALDOKETO REDUCTASE; CASPASE 3; CASPASE 9; OXIDOREDUCTASE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; CELL DAMAGE; CELL LOSS; CELL PROTECTION; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; NONHUMAN; PROTEIN EXPRESSION; RAT; UPREGULATION;

ALDEHYDES; ANIMALS; APOPTOSIS; ATHEROSCLEROSIS; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LIPID PEROXIDATION; LIPOPROTEINS; MALE; OXIDOREDUCTASES ACTING ON ALDEHYDE OR OXO GROUP DONORS; RATS; RATS, WISTAR;

RATTUS;

EID: 79957552424     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.12.018     Document Type: Conference Paper

References (52)

1. D. Steinberg, S. Parthasarathy, T.E. Carew, J.C. Khoo, J.L. Witztum, Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity, N. Engl. J. Med. 320 (1989) 915-924. (Pubitemid 19101597)
2. R. Ross, The pathogenesis of atherosclerosis: a perspective for the 1990s, Nature 362 (1993) 801-809. (Pubitemid 23132154)
3. I. Escargueil-Blanc, O. Meilhac, M.T. Pieraggi, J.F. Arnal, R. Salvayre, A. Nègre-Salvayre, Oxidized LDLs induce massive apoptosis of cultured human endothelial cells through a calcium-dependent pathway. Prevention by aurintricarboxylic acid, Arterioscler. Thromb. Vasc. Biol. 17 (1997) 331-339. (Pubitemid 27098192)
4. S. Dimmeler, J. Haendeler, J. Galle, A.M. Zeiher, Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. Amechanistic clue to the 'response to injury' hypothesis, Circulation 95 (1997) 1760-1763.
5. M. Harada-Shiba, M. Kinoshita, H. Kamido, K. Shimokado, Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells bycommonand unique mechanisms, J. Biol. Chem. 273 (1998) 9681-9687.
6. J. Frostegård, J. Nilsson, A. Haegerstrand, A. Hamsten, H. Wigzell, M. Gidlund, Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937, Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 904-908.
7. J.A. Berliner, M.C. Territo, A. Sevanian, S. Ramin, J.A. Kim, B. Bamshad, M. Esterson, A.M. Fogelman, Minimally modified low density lipoprotein stimulates monocyte endothelial interactions, J. Clin. Invest. 85 (1990) 1260-1266.
8. T. Henriksen, E.M. Mahoney, D. Steinberg, Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins, Proc. Natl. Acad. Sci. U.S.A. 78 (1981) 6499-6503. (Pubitemid 12179740)
9. A. Stiko-Rahm, A. Hultgårdh-Nilsson, J. Regnström, A. Hamsten, J. Nilsson, Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells, Arterioscler. Thromb. 12 (1992) 1099-1109.
10. W. Palinski, M.E. Rosenfeld, S. Ylä-Herttuala, G.C. Gurtner, S.S. Socher, S.W. Butler, S. Parthasarathy, T.E. Carew, D. Steinberg, J.L. Witztum, Low density lipoprotein undergoes oxidative modification in vivo, Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 1372-1376. (Pubitemid 19061548)
11. J.T. Salonen, S. Ylä-Herttuala, R. Yamamoto, S. Butler, H. Korpela, R. Salonen, K. Nyyssönen, W. Palinski, J.L. Witztum, Autoantibody against oxidised LDL and progression of carotid atherosclerosis, Lancet 339 (1992) 883-887.
12. P. Holvoet, G. Perez, Z. Zhao, E. Brouwers, H. Bernar, D. Collen, Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease, J. Clin. Invest. 95 (1995) 2611-2619.
13. H. Esterbauer, R.J. Schaur, H. Zollner, Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes, Free Radic. Biol. Med. 11 (1991) 81-128.
14. D.R. Petersen, J.A. Doorn, Reactions of 4-hydroxynonenal with proteins and cellular targets, Free Radic. Biol. Med. 37 (2004) 937-945. (Pubitemid 39164576)
15. M.E. Haberland, G.M. Fless, A.M. Scanu, A.M. Fogelman, Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocytemacrophages, J. Biol. Chem. 267 (1992) 4143-4151.
16. K. Uchida, S. Toyokuni, K. Nishikawa, S. Kawakishi, H. Oda, H. Hiai, E.R. Stadtman, Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis, Biochemistry 33 (1994) 12487-12494. (Pubitemid 24340455)
17. P. Eaton, J.M. Li, D.J. Hearse, M.J. Shattock, Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart, Am. J. Physiol. 276 (1999) H935-943.
18. K.N. Qin, K.C. Cheng, Structure and tissue-specific expression of the aldo-keto reductase superfamily, Biochemistry 33 (1994) 3223-3228.
19. S. Endo, T. Matsunaga, K. Horie, K. Tajima, Y. Bunai, V. Carbone, O. El-Kabbani, A. Hara, Enzymatic characteristics of an aldo-keto reductase family protein (AKR1C15) and its localization in rat tissues, Arch. Biochem. Biophys. 465(2007) 136-147. (Pubitemid 47283988)
20. S. Endo, T. Matsunaga, H. Mamiya, A. Hara, Y. Kitade, K. Tajima, O. El-Kabbani, Characterization of a rat NADPH-dependent aldo-keto reductase (AKR1B13) induced by oxidative stress, Chem. Biol. Interact. 178 (2009) 151-157.
21. H. Esterbauer, W. Weger, Über die Wirkungen von aldehyden auf gesunde und maligne zellen, 3. Mitt.: synthese von homologen 4-hydroxy-2-alkenalen, II, Monatsh. Chem. 98 (1967) 1994-2000.
22. S. Srivastava, A. Chandra, N.H. Ansari, S.K. Srivastava, A. Bhatnagar, Identification of cardiac oxidoreductase(s) involved in the metabolism of the lipid peroxidation-derived aldehyde-4-hydroxynonenal, Biochem. J. 329 (1998) 469-475. (Pubitemid 28055167)
23. N. Tanaka, K. Aoki, S. Ishikura, M. Nagano, Y. Imamura, A. Hara, K.T. Nakamura, Molecular basis for peroxisomal localization of tetrameric carbonyl reductase, Structure 16 (2008) 388-397. (Pubitemid 351324117)
24. S. Usui, T. Matsunaga, S. Ukai, T. Kiho, Growth suppressing activity for endothelial cells induced from macrophages by carboxymethylated curdlan, Biosci. Biotechnol. Biochem. 61 (1997) 1924-1925. (Pubitemid 127471792)
25. S. Kotamraju, E.A. Konorev, J. Joseph, B. Kalyanaraman, Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species, J. Biol. Chem. 275 (2000) 33585-33592.
26. T. Matsunaga, S. Kotamraju, S.V. Kalivendi, A. Dhanasekaran, J. Joseph, B. Kalyanaraman, Ceramide-induced intracellular oxidant formation, iron signaling, and apoptosis in endothelial cells: protective role of endogenous nitric oxide, J. Biol. Chem. 279 (2004) 28614-28624. (Pubitemid 38900144)
27. H.J. Martin, E. Maser, Role of human aldo-keto-reductase AKR1B10 in the protection against toxic aldehydes, Chem. Biol. Interact. 178 (2009) 145-150.
28. T. Nakajima, Y. Sakagishi, T. Katahira, A. Nagata, T. Kuwae, H. Nakamura, I. Inoue, K. Takahashi, S. Katayama, T. Komoda, Characterization of a specific monoclonal antibody 9F5-3a and the development of assay system for oxidized HDL, Biochem. Biophys. Res. Commun. 217 (1995) 407-411. (Pubitemid 26011728)
29. J. Folch, M. Lees, G.H. Sloane Stanley, A simple method for the isolation and purification of total lipids from animal tissues, J. Biol. Chem. 226 (1957) 497-509.
30. T. Matsunaga, T. Kamiya, D. Sumi, Y. Kumagai, B. Kalyanaraman, A. Hara, L-Xylulose reductase is involved in 9,10-phenanthrenequinone-induced apoptosis in human T lymphoma cells, Free Radic. Biol. Med. 44 (2008) 1191-1202.
31. A. Dhanasekaran, S. Kotamraju, S.V. Kalivendi, T. Matsunaga, T. Shang, A. Keszler, J. Joseph, B. Kalyanaraman, Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis, J. Biol. Chem. 279 (2004) 37575-37587. (Pubitemid 39195471)
32. H.J. Forman, J.M. Fukuto, T. Miller, H. Zhang, A. Rinna, S. Levy, The chemistry of cell signaling by reactive oxygen and nitrogen species and 4-hydroxynonenal, Arch. Biochem. Biophys. 477 (2008) 183-195.
33. R.M. LoPachin, T. Gavin, D.R. Petersen, D.S. Barber, Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: nucleophilic targets and adduct formation, Chem. Res. Toxicol. 22 (2009) 1499-1508.
34. I.A. Blair, Lipid hydroperoxide-mediated DNA damage, Exp. Gerontol. 36 (2001) 1473-1481.
35. Y.H. Shen, B. Utama, J. Wang, M. Raveendran, D. Senthil, W.J. Waldman, J.D. Belcher, G. Vercellotti, D. Martin, B.M. Mitchelle, X.L. Wang, Human cytomegalovirus causes endothelial injury through the ataxia telangiectasia mutant and p53 DNA damage signaling pathways, Circ. Res. 94 (2004) 1310-1317.
36. T. Miyashita, J.C. Reed, Tumor suppressor p53 is a direct transcriptional activator of the human bax gene, Cell 80 (1995) 293-299.
37. A. Sharma, R. Sharma, P. Chaudhary, R. Vatsyayan, V. Pearce, P.V. Jeyabal, P. Zimniak, S. Awasthi, Y.C. Awasthi, 4-Hydroxynonenal induces p53-mediated apoptosis in retinal pigment epithelial cells, Arch. Biochem. Biophys. 480 (2008) 85-94.
38. H. Raza, A. John, E.M. Brown, S. Benedict, A. Kambal, Alterations in mitochondrial respiratory functions, redox metabolism and apoptosis by oxidant 4-hydroxynonenal and antioxidants curcumin and melatonin in PC12 cells, Toxicol. Appl. Pharmacol. 226 (2008) 161-168.
39. J. Whitsett, M.J. Picklo Sr., J. Vasquez-Vivar, 4-Hydroxy-2-nonenal increases superoxide anion radical in endothelial cells via stimulated GTP cyclohydrolase proteasomal degradation, Arterioscler. Thromb. Vasc. Biol. 27 (2007) 2340-2347. (Pubitemid 350203948)
40. K. Uchida, M. Shiraishi, Y. Naito, Y. Torii, Y. Nakamura, T. Osawa, Activation of stress signaling pathways by the end product of lipid peroxidation. 4-Hydroxy-2-nonenal is a potential inducer of intracellular peroxide production, J. Biol. Chem. 274 (1999) 2234-2242.
41. T. Matsunaga, T. Nakajima, T. Miyazaki, I. Koyama, S. Hokari, I. Inoue, S. Kawai, H. Shimomura, S. Katayama, A. Hara, T. Komoda, Glycated high-density lipoprotein regulates reactive oxygen species and reactive nitrogen species in endothelial cells, Metabolism 52 (2003) 42-49.
42. Y. Jin, T.M. Penning, Aldo-keto reductases and bioactivation/ detoxication, Annu. Rev. Pharmacol. Toxicol. 47 (2007) 263-292.
43. A.A. Anwar, F.Y. Li, D.S. Leake, T. Ishii, G.E. Mann, R.C. Siow, Induction of heme oxygenase 1 by moderately oxidized low-density lipoproteins in human vascular smooth muscle cells: role of mitogen-activated protein kinases and Nrf2, Free Radic. Biol. Med. 39 (2005) 227-236. (Pubitemid 40814548)
44. Z.H. Chen, Y. Saito, Y. Yoshida, A. Sekine, N. Noguchi, E. Niki, 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2, J. Biol. Chem. 280 (2005) 41921-41927.
45. T. Ishii, K. Itoh, E. Ruiz, D.S. Leake, H. Unoki, M. Yamamoto, G.E. Mann, Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal, Circ. Res. 94 (2004) 609-616.
46. A.K. MacLeod, M. McMahon, S.M. Plummer, L.G. Higgins, T.M. Penning, K. Igarashi, J.D. Hayes, Characterization of the cancer chemopreventive Nrf2- dependent gene battery in human keratinocytes: demonstration that the Keap1-Nrf2 pathway, and not the Bach1-Nrf2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds, Carcinogenesis 30 (2009) 1571-1580.
47. K.Z. Liu, T.E. Cuddy, G.N. Pierce, Oxidative status of lipoproteins in coronary disease patients, Am. Heart J. 123 (1992) 285-290.
48. K. Uchida, M. Kanematsu, Y. Morimitsu, T. Osawa, N. Noguchi, E. Niki, Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins, J. Biol. Chem. 273 (1998) 16058-16066. (Pubitemid 28311374)
49. F.J. van Kuijk, A.N. Siakotos, L.G. Fong, R.J. Stephens, D.W. Thomas, Quantitative measurement of 4-hydroxyalkenals in oxidized low-density lipoprotein by gas chromatography-mass spectrometry, Anal. Biochem. 224 (1995) 420-424.
50. D. Lin, H.G. Lee, Q. Liu, G. Perry, M.A. Smith, L.M. Sayre, 4-Oxo-2-nonenal is both more neurotoxic and more protein reactive than 4-hydroxy-2-nonenal, Chem. Res. Toxicol. 18 (2005) 1219-1231. (Pubitemid 41170246)
51. N. Traverso, S. Menini, L. Cosso, P. Odetti, E. Albano, M.A. Pronzato, U.M. Marinari, Immunological evidence for increased oxidative stress in diabetic rats, Diabetologia 41 (1998) 265-270. (Pubitemid 28254819)
52. P. Sompol, W. Ittarat, J. Tangpong, Y. Chen, I. Doubinskaia, I. Batinic-Haberle, H.M. Abdul, D.A. Butterfield, D.K. St Clair, A neuronal model of Alzheimer's disease: an insight into the mechanisms of oxidative stress-mediated mitochondrial injury, Neuroscience 153 (2008) 120-130.